The Food and Drug Administration Wednesday authorized the emergency use of infusion pumps to counteract insufficient supplies needed for the continuous infusion of medications, total parenteral nutrition and other fluids into COVID-19 patients.

The agency said this includes infusion pumps with remote monitoring or remote manual control features that can help promote safe physical distances to reduce health care providers’ COVID-19 exposure.

FDA also updated its guidance for pharmacy compounders’ use of personal protective equipment.

The guidance, released yesterday, clarifies that intended-sterile drugs can be compounded in segregated compounding areas that are not within cleanrooms, assuming specific beyond-use dates are utilized. The agency said it adopted this policy to help assure patients’ access to necessary medications while reducing the risks of compounding when standard PPE are not available.

Related News Articles

Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…
Headline
The Health Resources and Services Administration this week opened the Provider Relief Fund reporting portal through Dec. 2 for health care providers…
Headline
Five medical organizations this week released a toolkit for clinicians in post-acute and long-term care settings about the benefits of the COVID-19 bivalent…
Headline
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according…
Headline
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics…